INTERACT4 Expansion: Seeing if a quick GFAP test can help ID brain bleeds before hospital care
Official title: INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
Run by The George Institute · NCT07231315 · Data updated 2026-11-12
This observational study tests whether a point-of-care GFAP test in pre-hospital care can help identify intracerebral hemorrhage in adults with suspected acute stroke.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 163 (estimated) |
| Sponsor | The George Institute Academic / other |
| Locations | 6 sites (Sydney, New South Wales and 5 other locations) |
| Status | Recruiting |
| Started | September 18, 2026 |
| Main results expected | March 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07231315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with sudden stroke-like symptoms (FAST ≥2 with arm deficit), within 3 hours of last seen well, and SBP ≥150 mmHg.
✕Probably not a fit
Patients with coma, severe comorbidities, epilepsy history, recent head injury, or low blood glucose may not benefit from this pre-hospital testing approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an investigator-initiated, multi-centre, open-label, single-arm prospective observational study evaluating the feasibility of setting up a trial that uses a GFAP point-of-care test to identify intracerebral hemorrhage in patients with acute stroke-like symptoms before arrival at the hospital. Eligible participants are adults with suspected stroke within 3 hours of last known well, with high blood pressure and specific motor/face-speech deficits, excluding those with coma, severe comorbidities, epilepsy history, recent head injury, or hypoglycemia. The study is conducted at three sites in New South Wales, led by The George Institute, and uses LVOne as the intervention framework. Primary aim is feasibility of trial conduct and pre-hospital testing workflows. Outcomes will inform larger studies on pre-hospital triage and treatment pathways for stroke patients.
Why it matters
Potential benefit: If feasible, this approach could streamline pre-hospital triage and speed targeted care for intracerebral hemorrhage.
How similar studies have gone: Previous work has explored biomarkers for stroke triage; this study tests feasibility in a pre-hospital setting and is relatively novel in its specific GFAP, pre-hospital context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults (age ≥18 years); 2. Acute syndrome that is due to presumed acute stroke, defined as FAST (Face, Arm, Speech, Time) scores of ≥2 with an arm motor deficit; 3. Time ≤3 hours from last seen well; 4. Systolic BP (SBP) ≥150mmHg. Exclusion Criteria: 1. Participants in coma (no response to tactile/verbal stimulation); or/and do not respond to "P" or "U" on the alert/verbal/painful/unresponsive (APVU) responsiveness scale; 2. Severe known co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability \[needing help\]); 3. Known history of epilepsy or seizure at onset; 4. Recent head injury (where there is potential for another type of intracranial haemorrhage or head trauma); 5. Hypoglycaemia (glucose\<4.0 mmol/L) as measured in the ambulance.
Where it's running
-
Nepean Hospital
Sydney, New South Wales, Australia Recruiting -
New South Wales Ambulance
Sydney, New South Wales, Australia Recruiting -
Royal North Shore Hospital
Sydney, New South Wales, Australia Recruiting -
St George Hospital
Sydney, New South Wales, Australia Recruiting -
Wollongong Hospital
Sydney, New South Wales, Australia Recruiting -
Liverpool Hospital
Sydney, New South Wales, Australia Not yet recruiting
Study contacts
- Study coordinator: Craig Anderson, MD
- Email: canderson@georgeinstitute.org.au
- Phone: +61 4039448107
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Smartphone-based EEG to detect hidden awareness in ICU patients with brain injuries
Researchers will test a smartphone-enabled EEG to see if it can reveal Cognitive Motor Dissociation in ICU patients who can’t show commands at bedside.
-
Chinese multicenter group studies spontaneous intracerebral hemorrhage in adults
This study tests how a large group of adults with spontaneous intracerebral hemorrhage (and a healthy control group) progress over time to understand outcomes and determinants of recovery.
-
Rapid Evacuation and Access of Cerebral Hemorrhage Registry: observing minimally invasive surgery outcomes
This registry collection tests how minimally invasive brain-bleed procedures work in real patients with acute spontaneous intracerebral hemorrhage.
-
Single triple-combination blood pressure pill after intracerebral hemorrhage
This trial tests whether a single pill combining amlodipine, valsartan, and hydrochlorothiazide helps adults who recently had an intracerebral hemorrhage control their blood pressure.
-
Vitamin D treatment after intracerebral hemorrhage
This will try giving higher-dose vitamin D to adults within 96 hours of an intracerebral hemorrhage to see if it helps clear the bleed faster and is safe.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.